RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
ValenzaBio Inc | antibody for inflammatory eye disease | Series A | USD 70,000,000 | ||
|
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A | USD 71,000,000 | ||
|
Perfect Day Inc | Series C | USD 140,000,000 | |||
|
Quell Therapeutics Ltd | Developer of engineered T regulatory cell therapies. | Series A | GBP 35,000,000 | ||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Aquaro Histology Inc | Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. | Series A | USD 9,810,879 | ||
|
|
3SBio Inc | IPO | HKD 5,510,000,000 | |||
|
|
Wyeth Pharmaceuticals | Acquisition | USD 68,000,000,000 |
MOST ACTIVE INVESTORS
MOST ACTIVE ACQUIRERS
| Pfizer Inc | US | 1 |
BEST FUNDED
Biotechnology company focused on oncology and autoimmune disorders.
![[current-page:title] logo](/sites/default/files/styles/thumbnail/public/default_images/_company.png?itok=PsC3hz2r)
Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.
